Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 4 5Phase 2 4Phase NA 3

Status

Unknown 2Recruiting 2Completed 2

Sponsor Class

OTHER 6NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 3Lymphoid 2

Conditions

Carcinoma, Hepatocellular 2Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Hepatitis B 1Gastrointestinal Neoplasms 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × OTHER × entecavir × Clear all
NCT07493109 2026-03-25

Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOP

The First Hospital of Jilin University

Phase 3 Recruiting
200 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT06966232 2025-05-11

Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers

Sun Yat-sen University

Phase 3 Recruiting
136 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT02650271 2024-01-23

Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC

Guangxi Medical University

Phase 3 Completed
240 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04539119 2020-09-04

Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA

Ruijin Hospital

Phase 3 Unknown
120 enrolled
Lymphoid

Lymphoma, B-Cell

NCT04392700 2020-05-19

A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection

Sun Yat-sen University

Phase 3 Unknown
706 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01580202 2017-06-29

Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine

Seoul National University Hospital

Phase 3 Completed
180 enrolled

Hepatitis B, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡